{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:51:04Z","timestamp":1777679464152,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,12]]},"DOI":"10.7759\/cureus.105119","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:40:47Z","timestamp":1773340847000},"source":"Crossref","is-referenced-by-count":1,"title":["Anti-GQ1b-Positive Miller Fisher Syndrome Following Pfizer Bivalent COVID-19 Vaccination"],"prefix":"10.7759","author":[{"given":"Abdul K","family":"Naasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirah","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya D","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Miller Fisher syndrome","author":"Rocha Cabrero F","year":"2025","unstructured":"Rocha Cabrero F, Morrison EH. Miller Fisher syndrome. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1250774","article-title":"Miller Fisher syndrome: an updated narrative review","volume":"14","author":"Noioso CM","year":"2023","unstructured":"Noioso CM, Bevilacqua L, Acerra GM, et al.. Miller Fisher syndrome: an updated narrative review. Front Neurol. 2023, 14:1250774. 10.3389\/fneur.2023.1250774","journal-title":"Front Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13687","article-title":"Miller Fisher syndrome following COVID-19 vaccines: a scoping review","volume":"146","author":"Kim JE","year":"2022","unstructured":"Kim JE, Yoon BA, Kim YH, Kim JK, Bae JS. Miller Fisher syndrome following COVID-19 vaccines: a scoping review. Acta Neurol Scand. 2022, 146:604-9. 10.1111\/ane.13687","journal-title":"Acta Neurol Scand"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27 Suppl","author":"Asbury AK","year":"1990","unstructured":"Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome. Ann Neurol. 1990, 27 Suppl:S21-4. 10.1002\/ana.410270707","journal-title":"Ann Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410310619","article-title":"Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome","volume":"31","author":"Chiba A","year":"1992","unstructured":"Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992, 31:677-9. 10.1002\/ana.410310619","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62189-8","article-title":"Association between Guillain-Barr\u00e9 syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis","volume":"381","author":"Salmon DA","year":"2013","unstructured":"Salmon DA, Proschan M, Forshee R, et al.. Association between Guillain-Barr\u00e9 syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet. 2013, 381:1461-8. 10.1016\/S0140-6736(12)62189-8","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-018-0542-y","article-title":"Autonomic involvement in Guillain-Barr\u00e9 syndrome: an update","volume":"29","author":"Zaeem Z","year":"2019","unstructured":"Zaeem Z, Siddiqi ZA, Zochodne DW. Autonomic involvement in Guillain-Barr\u00e9 syndrome: an update. Clin Auton Res. 2019, 29:289-99. 10.1007\/s10286-018-0542-y","journal-title":"Clin Auton Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002063.pub6","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","volume":"2014","author":"Hughes RA","year":"2014","unstructured":"Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2014, 2014:CD002063. 10.1002\/14651858.CD002063.pub6","journal-title":"Cochrane Database Syst Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.56.8.1104","article-title":"Clinical features and prognosis of Miller Fisher syndrome","volume":"56","author":"Mori M","year":"2001","unstructured":"Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001, 56:1104-6. 10.1212\/wnl.56.8.1104","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029333","article-title":"Miller Fisher syndrome after COVID-19 vaccination: case report and review of literature","volume":"101","author":"Siddiqi AR","year":"2022","unstructured":"Siddiqi AR, Khan T, Tahir MJ, Asghar MS, Islam MS, Yousaf Z. Miller Fisher syndrome after COVID-19 vaccination: case report and review of literature. Medicine (Baltimore). 2022, 101:e29333. 10.1097\/MD.0000000000029333","journal-title":"Medicine (Baltimore)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10124-x","article-title":"Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases","volume":"268","author":"Abu-Rumeileh S","year":"2021","unstructured":"Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021, 268:1133-70. 10.1007\/s00415-020-10124-x","journal-title":"J Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/425635-anti-gq1b-positive-miller-fisher-syndrome-following-pfizer-bivalent-covid-19-vaccination","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:40:48Z","timestamp":1773340848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/425635-anti-gq1b-positive-miller-fisher-syndrome-following-pfizer-bivalent-covid-19-vaccination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.105119","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,12]]}}}